ProChem Strengthens Its Hanau Location
ProChem Acquires Active Ingredient Production Facilities from Evonik at the Wolfgang Industrial Park
Advertisement
Evonik and ProChem have signed an agreement for the sale of selected active ingredient production facilities at the Hanau site. The ProChem Group, an established contract manufacturer of chemical and pharmaceutical products, took over the facilities in June.
Thomas Hermann of Evonik Healthcare and Gerhard Jakobi, Managing Partner of the ProChem Group/ProChem InnoTec GmbH (front row, from left), along with Evonik site managers Kerstin Oberhaus and Jochen Pohl, Managing Director of ProChem GmbH, are pleased with the signing of the contract.
Evonik Industries
For many years, Evonik manufactured active pharmaceutical ingredients, intermediates, and lipids for the pharmaceutical industry at the Wolfgang Industrial Park. As part of a realignment of its growth strategy, the company will discontinue the production of keto acids in Hanau by the end of 2025.
Evonik will continue to operate the pharmaceutical lipid facility in Hanau and supply its customers with clinical and small commercial quantities from there.
ProChem is taking over Evonik’s existing facilities, structures, and permits. This will enable the new site partner at the Wolfgang Industrial Park to ramp up production quickly. ProChem plans to expand its workforce at the industrial park to around 30 employees over the course of the year.
“With the Hanau site, we are gaining state-of-the-art facilities, quality-assured processes, and an excellent industrial infrastructure,” says Dr. Jörg Blumhoff, Sales Director of the ProChem Group. “This enables us to significantly expand our service portfolio and offer our customers even more comprehensive, scalable, and regulatory-compliant solutions in the future.”
Evonik Site Manager Kerstin Oberhaus emphasizes: “With ProChem’s arrival, we are gaining a strong industrial partner that will further develop the existing facilities and thereby strengthen the long-term competitiveness of the Wolfgang Industrial Park. We warmly welcome ProChem and look forward to working together.”
The Hanau site significantly expands the ProChem Group’s existing production network and opens up new opportunities for customers in demanding and regulated markets. A key milestone: Following the acquisition, the ProChem Group will be able to offer production under GMP conditions. In doing so, the company is specifically responding to the growing demand for high-quality, regulatory-compliant contract manufacturing.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.